Sit Investment Associates Inc Ionis Pharmaceuticals Inc Transaction History

Sit Investment Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$42.88 - $53.7 $588,528 - $737,032	-13,725 Closed	0 $0
Q1 2018 Apr 20, 2018	SELL	$44.08 - $55.05 $462,840 - $578,025	-10,500 Reduced 43.34%	13,725 $605,000
Q4 2017 Jan 10, 2018	SELL	$50.3 - $64.39 $25,150 - $32,195	-500 Reduced 2.02%	24,225 $1.22 Million
Q3 2017 Oct 18, 2017	BUY	$45.56 - $59.57 $1.13 Million - $1.47 Million	24,725	24,725 $1.25 Million

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Sit Investment Associates Inc with notifications on news.